Yes, but the business team is more likely to be competent in evaluating the business plans than the government. After all, they've done this sort of thing befor

Yes, but the business team is more likely to be competent in evaluating the business plans than the government. After all, they've done this sort of thing before and they're incentivized to be objective and develop a popular, effective drug so they can rake in the cash. The government has other priorities (diversity, "fairness in procurement", getting some of the money back in political donations, etc.). That's why incompetents like CGI Federal get massive contracts like healthcare.gov. They're clearly bad at writing software and excellent at navigating procurement. I don't want the pharmaceutical research industry, bad as it is, looking like that.